Researchers identified how SARS-CoV-2 targets and manipulates specific lung cells, using innovative techniques to trace the virus’s impact on the cells’ gene expression, revealing insights into early COVID-19 pathogenesis.
Atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit | Psychedelic Invest
atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Jefferies Inaugural Biotech